(11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one

C35H39N7O2S — CID 171465001

IUPAC(11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
SMILESCc1cccc(C)c1-c1cc2nc(n1)NSc1cccc(c1)C(=O)N(Cc1ncc(N3CC(C)(C)C3)cn1)[C@H](CC1CC1)CO2
InChIInChI=1S/C35H39N7O2S/c1-22-7-5-8-23(2)32(22)29-15-31-39-34(38-29)40-45-28-10-6-9-25(14-28)33(43)42(26(19-44-31)13-24-11-12-24)18-30-36-16-27(17-37-30)41-20-35(3,4)21-41/h5-10,14-17,24,26H,11-13,18-21H2,1-4H3,(H,38,39,40)/t26-/m1/s1
InChIKeyOLZNCGMXQOUAEU-AREMUKBSSA-N
MW621.81 g/mol
LogP6.72
Rot. Bonds6

About (11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one

(11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one (PubChem CID 171465001) has the molecular formula C35H39N7O2S and a molecular weight of 621.81 g/mol. Its IUPAC name is (11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one.

Molecular Properties

Compound Name(11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
PubChem CID171465001
Molecular FormulaC35H39N7O2S
Molecular Weight621.81 g/mol
Exact Mass621.29
IUPAC Name(11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
SMILESCc1cccc(C)c1-c1cc2nc(n1)NSc1cccc(c1)C(=O)N(Cc1ncc(N3CC(C)(C)C3)cn1)[C@H](CC1CC1)CO2
InChIInChI=1S/C35H39N7O2S/c1-22-7-5-8-23(2)32(22)29-15-31-39-34(38-29)40-45-28-10-6-9-25(14-28)33(43)42(26(19-44-31)13-24-11-12-24)18-30-36-16-27(17-37-30)41-20-35(3,4)21-41/h5-10,14-17,24,26H,11-13,18-21H2,1-4H3,(H,38,39,40)/t26-/m1/s1
InChIKeyOLZNCGMXQOUAEU-AREMUKBSSA-N
XLogP6.72
TPSA96.37 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500621.81
LogP ≤ 56.72
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'sulphur_nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one?
The IUPAC name of (11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one (CID 171465001) is (11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one.
What is the SMILES notation for (11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one?
The canonical SMILES for (11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one is Cc1cccc(C)c1-c1cc2nc(n1)NSc1cccc(c1)C(=O)N(Cc1ncc(N3CC(C)(C)C3)cn1)[C@H](CC1CC1)CO2.
What is the InChIKey of (11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one?
The InChIKey is OLZNCGMXQOUAEU-AREMUKBSSA-N. The full InChI is InChI=1S/C35H39N7O2S/c1-22-7-5-8-23(2)32(22)29-15-31-39-34(38-29)40-45-28-10-6-9-25(14-28)33(43)42(26(19-44-31)13-24-11-12-24)18-30-36-16-27(17-37-30)41-20-35(3,4)21-41/h5-10,14-17,24,26H,11-13,18-21H2,1-4H3,(H,38,39,40)/t26-/m1/s1.
What are the key properties of (11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one?
(11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one has a molecular weight of 621.81 g/mol, XLogP of 6.72, 6 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (11R)-11-(cyclopropylmethyl)-12-[[5-(3,3-dimethylazetidin-1-yl)pyrimidin-2-yl]methyl]-6-(2,6-dimethylphenyl)-9-oxa-2-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one is sourced from PubChem (CID 171465001), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).